Global Botulinum Toxin Market Trends/Analysis Report 2022: A $15.4 Billion Market by 2030 – Increasing Application in Therapeutic Applications Coupled with Growing R&D Initiatives – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Botulinum Toxin Market Size, Share & Trends Analysis Report by Product Type (Type A, Type B), by Application (Therapeutic, Aesthetic), by End Use, by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering.

The global botulinum toxin market size is expected to reach USD 15.4 billion by 2030, registering a CAGR of 11.5% from 2022 to 2030

Botulinum toxin is used for both therapeutic and aesthetic applications. Nowadays, the drug is highly adopted for aesthetic procedures. For instance, Botox is a non-invasive cosmetic procedure and is used to reduce forehead creases, facial fine lines, wrinkles, and crow’s feet among others.

The demand for botulinum toxin is expected to grow during the forecast period owing to the growing demand for minimally invasive or non-invasive procedures in aesthetics. Furthermore, increasing application in therapeutic applications, coupled with growing R&D initiatives, is expected to expand the market.

Population aged above 40 years are focusing on the physical features and wish to have a younger look. Thus, rising emphasis on aesthetic beauty, for instance, lip treatments by women, especially in developed countries is anticipated to fuel the industry growth. Also, botulinum toxin is used to treat several age-related conditions such as glabellar lines, crow’s feet, and forehead lines.

Hence, people above the age of 40 are more vulnerable to such signs of aging. Therefore, procedures of botulinum toxin are gaining more popularity among individuals aged between 40-55 years, thereby augmenting the industry growth. Furthermore, rising cases of chronic disorders such as migraine and cervical dystonia are likely to drive the market.

The COVID-19 outbreak has significantly affected the market. Initially, due to lockdown and global restrictions being imposed in most countries, many aesthetic treatments and procedures were halted. The COVID-19 pandemic has caused a huge disruption in the supply chain of the overall medical industry.

However, the sales of botulinum toxins such as botox observed a surge due to the increased demand during the pandemic. Several plastic surgeons and dermatologists are accrediting the boom to individuals wishing to put their finest appearance for online meetings and conferences and greater time to attend consultations and recover from procedures.

Botulinum Toxin Market Report Highlights

• The type A product type segment dominated the market in 2021. This is because type A products including Dysport and Botox are commercially available in the market in most countries and have been clinically tested and proven to be safe and effective in the long term with minimal side effects
• The aesthetic application segment is expected to register a significant CAGR of 12.2% during the forecast period. Growing concerns over cosmetic features in developed and developing countries have led to a rise in the number of aesthetic procedures
• North America dominated the global market in 2021 with a revenue share of over 35.0% owing to the rising technological advancements for cosmetic treatments and the increasing number of specialists and service providers
• Asia Pacific is expected to register the highest CAGR over the forecast period owing to the growing patient population, rising awareness regarding aesthetic procedures, and rapid technological advancements

Market Dynamics

Market Driver Analysis

• Increasing Number Of Patients Having Neurological Disorders
• Rising Preference For Non-Invasive Or Minimally Invasive Procedures
• Increasing Concern Regarding Aesthetic Appearance In 40-54 Age Group Has Increased The Adoption Rate

Market Restraint Analysis

• High cost of cosmetic procedure

Penetration & Growth Prospect Mapping

Botulinum Toxin: Market Analysis Tools

• Industry Analysis – Porter’s
• Pestel Analysis

Company Profiles

• Ipsen Group
• Allergen Inc.
• Medy-Tox, Inc.
• Metabiologics
• Merz Pharma
• US WorldMeds
• Evolus
• Galderma
• Lanzhou Institute Of Biological Products

For more information about this report visit https://www.researchandmarkets.com/r/ed4f9t

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900